Ortoncelli M - Search Results

1

Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation.

Chiricozzi A, Ortoncelli M, Schena D, Gori N, Ferrucci SM, Babino G, Napolitano M, Fargnoli MC, Stingeni L, Rossi M, Romanelli M, Balestri R, Pellegrino M, Parodi A, Bertoldi AM, Palazzo G, Antonelli F, Pitino A, Tripepi G, Fabbrocini G, Balato A, Marzano AV, Girolomoni G, Ribero S, Peris K. Chiricozzi A, et al. Among authors: ortoncelli m. Am J Clin Dermatol. 2023 Nov;24(6):963-964. doi: 10.1007/s40257-023-00813-4. Epub 2023 Aug 19. Am J Clin Dermatol. 2023. PMID: 37597128 Free PMC article. No abstract available.

2

Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients.

Osella-Abate S, Savoia P, Quaglino P, Fierro MT, Leporati C, Ortoncelli M, Bernengo MG. Osella-Abate S, et al. Among authors: ortoncelli m. Br J Cancer. 2003 Oct 20;89(8):1457-62. doi: 10.1038/sj.bjc.6601197. Br J Cancer. 2003. PMID: 14562017 Free PMC article. Clinical Trial.

3

Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.

Quaglino P, Osella-Abate S, Cappello N, Ortoncelli M, Nardò T, Fierro MT, Cavallo F, Savoia P, Bernengo MG. Quaglino P, et al. Among authors: ortoncelli m. Melanoma Res. 2007 Apr;17(2):75-82. doi: 10.1097/CMR.0b013e328054c667. Melanoma Res. 2007. PMID: 17496782

4

Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study.

Quaglino P, Marenco F, Osella-Abate S, Cappello N, Ortoncelli M, Salomone B, Fierro MT, Savoia P, Bernengo MG. Quaglino P, et al. Among authors: ortoncelli m. Ann Oncol. 2010 Feb;21(2):409-414. doi: 10.1093/annonc/mdp325. Epub 2009 Jul 21. Ann Oncol. 2010. PMID: 19622589 Free article.

5

Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.

Bernengo MG, Quaglino P, Comessatti A, Ortoncelli M, Novelli M, Lisa F, Fierro MT. Bernengo MG, et al. Among authors: ortoncelli m. Haematologica. 2007 Jun;92(6):784-94. doi: 10.3324/haematol.11127. Haematologica. 2007. PMID: 17550851 Free article. Clinical Trial.

6

Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.

Gisondi P, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, Girolomoni G, Naldi L; Psocare Study Group. Gisondi P, et al. J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e30-41. doi: 10.1111/j.1468-3083.2012.04450.x. Epub 2012 Feb 7. J Eur Acad Dermatol Venereol. 2013. PMID: 22313340

7

Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry.

Piaserico S, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, Peserico A, Naldi L; Psocare Study Group. Piaserico S, et al. J Am Acad Dermatol. 2014 Feb;70(2):257-62.e3. doi: 10.1016/j.jaad.2013.10.019. Epub 2013 Dec 16. J Am Acad Dermatol. 2014. PMID: 24355410 Free article.

8

Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry.

Gisondi P, Cazzaniga S, Chimenti S, Maccarone M, Picardo M, Girolomoni G, Naldi L; Psocare Study Group. Gisondi P, et al. Br J Dermatol. 2015 Jun;172(6):1613-1620. doi: 10.1111/bjd.13539. Epub 2015 Mar 17. Br J Dermatol. 2015. PMID: 25401733

9

Efficacy of dupilumab in prurigo nodularis in elderly patient.

Giura MT, Viola R, Fierro MT, Ribero S, Ortoncelli M. Giura MT, et al. Among authors: ortoncelli m. Dermatol Ther. 2020 Jan;33(1):e13201. doi: 10.1111/dth.13201. Epub 2019 Dec 28. Dermatol Ther. 2020. PMID: 31856368

10

Median canaliform nail dystrophy of Heller in a patient with atopic dermatitis: 'miraculous' healing with dupilumab.

Giura MT, Viola R, Dika E, Ribero S, Ortoncelli M. Giura MT, et al. Among authors: ortoncelli m. Clin Exp Dermatol. 2020 Jul;45(5):601-602. doi: 10.1111/ced.14169. Epub 2020 Jan 29. Clin Exp Dermatol. 2020. PMID: 31889326 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page